PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF endometritis and Metro-MUST-agalactia in sows and drugs based on it

摘要

1. A pharmaceutical composition for the prevention and treatment of endometritis and mastitis-metritis-agalactia sows comprising oxytocin as myotonic agent used in endometritis and mastitis-metritis-agalactia sows with primary generic weakness, characterized in that the expanding use of oxytocin on all sows exposed metritis-mastitis-agalactia and endometritis, it allows to achieve therapeutic effect by the use of the antibiotic ciprofloxacin, further comprises vitamin A, vitamin E, and additional but comprises a substrate in the form of emulsions in the following ratio, wt. %: 2. Composition according to claim. 1, characterized in that the oxytocin content of 4.0 IU / ml, and ciprofloxacin lactate 10 wt. .3%. Composition according to claim. 1, characterized in that the oxytocin content of 6.0 IU / ml, and ciprofloxacin lactate 15 wt. %.4. Animal medicine for preventing and treating mastitis-metritis-agalactia and endometritis in emulsion form for intramuscular administration comprising a composition according to claim. 2.5. A pharmaceutical composition for the prevention and treatment of endometritis and metritis-mastitis-agalactia sows comprising oxytocin as myotonic means, and antibiotics, is used for endometritis and metritis-mastitis-agalactia sows with primary generic weakness, characterized in that the expanding use of oxytocin on all sows exposed metritis-mastitis-agalactia and endometritis, allows to achieve therapeutic effect by the use of antibiotic: ceftiofur or gentamicin used as a corolla trimyshechnyh injection further comprises vitamin A, vitamin E and optional